IMO, this release from Wotton amounts to a total disgrace from the likes of a ceo.
His comments are extremely cleverly worded but, imo, nowhere do they confirm that the financing was successfully completed for the full amount sought by the company and even more importantly, something concrete for investors on the actual start of Phase 2? If Ocata's 'well positione' to start Phase 2 give us some more specifics.
That could just mean they have an approved plan worked out with the FDA months and months ago.
Well positioned could mean anything and anytime in ceo speak, but to investors it's crucial information on what it does and does not mean.
More 'noise', this time from the ceo and we truly have no idea what he's really saying and how it effects our feelings and assessment of the Ocata.
The more one ponders and assessess the supposed credibility and connections of the Ocata Board and Wotton, etc., the more I, for one, am completely unimpressed and downright flabbergasted at how these so professionally 'connected' individuals and their supposed superior management skills, verge on coming across in the case of Ocata as just another high paid gig in another biotech for their resumes and frankly just a charade.
It's important to keep in mind, imo, that daily share price means just about nothing, except that we can be sure it's still the 'old game' being manipulated and controlled by the mm, hedgies and ETF's as a lucrative source on income for them on every trade (and similar parallels can easily be drawn for Ocata management, who by the way, are now asking for even more perks! Just unbelievable but so typical of these guys and gals in start up biotechs, history shows).
News 
Market Data 
Discover 
AI
